Full-Time

Vice President

Commercial Development, Obesity

Confirmed live in the last 24 hours

Pfizer

Pfizer

10,001+ employees

Develops and manufactures vaccines and medicines

Biotechnology
Healthcare

Compensation Overview

$262.1k - $436.8kAnnually

+ Bonus

Senior, Expert

No H1B Sponsorship

Cambridge, MA, USA + 2 more

More locations: Phoenixville, PA, USA | New York, NY, USA

Eligible for Relocation Package.

Category
Strategy Development
Business Development
Business & Strategy
Required Skills
Market Research
Requirements
  • BS/BA with 20 years of experience, MS/MBA with 18 years of experience or PhD/JD with 15 years of experience working in the biopharmaceutical industry in strategy, commercial development or marketing and sales roles with increasing responsibilities, complexity and accountabilities; experience working in global markets such as the European Union, Japan or other major markets is highly desirable
  • Experience in obesity and diseases where obesity can impact patient outcomes
  • Experience in global marketing and in-line marketing
  • Technical expertise in end-to-end lifecycle management of a brand, launch planning and execution, and disease area assessment; commercial development/ support of R&D through the drug development process; and evaluation of business development and pipeline opportunities
  • Effectively communicates with and influences others and seen as a thought partner to senior leaders in the organization and uses effective persuasion to gain acceptance of ideas
  • Demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact
Responsibilities
  • Develop and execute on a holistic Obesity Platform strategic vision to balance near-term and long-term priorities and commit to a course of action to accomplish established goals
  • Provide strategic thinking to allow for identification of future market opportunities, review of the franchise portfolio and prioritization of opportunities for internal research, and external opportunities for potential acquisition or partnering
  • Ensure the commercial perspective and strategy is well articulated, communicated to, and agreed by the relevant parties including clinical research and regulatory affairs
  • Build out, lead and develop an industry leading team to deliver on the scope and remit of the Obesity Category
  • Direct the development of life cycle plans for compounds from IND stage through loss of exclusivity
  • Oversee pipeline program commercial assessment, market research and development strategies
  • Provide oversight into the development of pipeline products including an integrated evidence plan that will differentiate the product for marketing and reimbursement, identify clinical endpoints and outcomes for clinical trials and real-world evidence generation that are meaningful for physicians and patients, and lead to product differentiation
  • Forge strong working relationships with R&D/Business Development/Biopharma partners (Commercial, Medical, Access), cross functional leadership and senior executives
  • Support assessment, evaluation, and integration of Business Development deals
  • Lead by example, respecting Pfizer core values

Pfizer is a biopharmaceutical company that focuses on creating and producing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold to various clients such as governments, healthcare providers, and patients around the world. Pfizer's products include vaccines, oncology treatments, and other specialized medicines. A notable achievement is its partnership with BioNTech to develop a vaccine for COVID-19, which has played a significant role in addressing the pandemic. Pfizer aims to improve public health by ensuring access to vaccines, especially for underserved populations, and continues to grow its product offerings with new approvals and treatments.

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Pfizer's significant investments in companies like CellCentric and Caribou Biosciences indicate a strong focus on expanding its oncology and cell therapy capabilities.
  • The company's proactive approach in securing investments and partnerships positions it well for future growth and innovation in the biopharmaceutical sector.
  • Pfizer's involvement in funding rounds for promising biotech firms suggests potential for lucrative returns and strategic advancements in healthcare solutions.

What critics are saying

  • The slowdown in demand for COVID-19 vaccines could impact Pfizer's revenue and market perception.
  • Activist investor involvement, such as Starboard Value's $1 billion stake, may lead to pressure for strategic changes that could affect company stability.

What makes Pfizer unique

  • Pfizer's strategic partnerships and investments in innovative biotech companies like Promise Bio and Enara Bio highlight its commitment to cutting-edge research and development.
  • The company's collaboration with BioNTech for the COVID-19 vaccine showcases its ability to rapidly respond to global health crises, setting it apart from many competitors.
  • Pfizer's diverse portfolio, including oncology and specialized medicines, ensures a broad market reach beyond just vaccines.

Help us improve and share your feedback! Did you find this helpful?